会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof
    • 用于治疗和预防心脏组织变性的组合物和方法及其用途
    • US08217157B2
    • 2012-07-10
    • US10557873
    • 2004-05-18
    • Hina W. ChaudhryDebra J. Wolgemuth
    • Hina W. ChaudhryDebra J. Wolgemuth
    • C07H21/02C07H21/04A61K48/00
    • A61K38/1703A61K38/12A61K38/1709G01N33/567G01N33/6893G01N2333/4739G01N2800/32
    • The present invention provides methods for promoting generation of heart tissue, and for treating and preventing heart tissue degeneration. Additionally, the present invention provides a therapeutic composition comprising a cyclin-associated agent, and a kit comprising the composition. The present invention further provides a heart tissue cell, a sidepopulation progenitor cell, and a stem cell in which cyclin is augmented. Also provided are cell lines comprising these cells, screening methods using the cell lines, and drugs identified by these methods. The present invention further provides in vitro systems for use in screening candidate drugs for at least one cardiotoxic effect and/or for synergy with cyclin in the treatment and prevention of heart tissue degeneration. Finally, the present invention provides use of a cyclin-associated agent in the generation of heart tissue, and use of a cyclin associated agent in the treatment or prevention of heart tissue degeneration.
    • 本发明提供促进心脏组织产生,以及治疗和预防心脏组织变性的方法。 另外,本发明提供了包含细胞周期蛋白相关药物的治疗组合物和包含该组合物的试剂盒。 本发明还提供了一种心脏组织细胞,侧支祖细胞和其中增殖细胞周期蛋白的干细胞。 还提供了包含这些细胞的细胞系,使用细胞系的筛选方法以及通过这些方法鉴定的药物。 本发明进一步提供用于筛选候选药物至少一种心脏毒性作用的体外系统和/或用于与细胞周期蛋白协同治疗和预防心脏组织变性的体外系统。 最后,本发明提供细胞周期蛋白相关药物在产生心脏组织中的用途,以及细胞周期蛋白相关药物在治疗或预防心脏组织变性中的用途。
    • 5. 发明申请
    • METHODS OF CARDIAC REPAIR
    • 心脏修复方法
    • US20130142762A1
    • 2013-06-06
    • US13671396
    • 2012-11-07
    • Hina W. CHAUDHRY
    • Hina W. CHAUDHRY
    • A61K35/50A61K35/12
    • A61K35/50A61K35/12
    • Provided herein is a new method to isolate and expand cardiac progenitor/stem cells from a placenta, which produces a cell population enriched in multipotent functional progenitor/stem cells. Cardiac progenitor/stem cells isolated by this method maintain their self-renewal character in vitro and differentiate into normal cells in myocardium, including cardiomyocytes, endothelial cells, and smooth muscle cells, after transplantation into ischemic hearts. Also provided in this application are substantially pure populations of multipotent cardiac progenitor/stem cells, and their use to treat and prevent diseases and injuries, including those resulting from myocardial infarction. A model for assessing the potential of cardiac stem cells for treatment of myocardial infarction is also provided.
    • 本文提供了一种从胎盘分离和扩增心脏祖细胞/干细胞的新方法,其产生富含多能功能性祖细胞/干细胞的细胞群。 通过该方法分离的心脏祖细胞/干细胞在体外维持其自我更新特征,并在移植到缺血性心脏中后分化成心肌中的正常细胞,包括心肌细胞,内皮细胞和平滑肌细胞。 本申请中还提供了基本上纯粹的多能心脏祖细胞/干细胞群,以及它们用于治疗和预防疾病和损伤的用途,包括由心肌梗死引起的疾病和损伤。 还提供了用于评估心脏干细胞用于治疗心肌梗塞的潜力的模型。